The FDA has approved Zuranolone, a groundbreaking pill for postpartum depression, promising noticeable improvements in as few as three days.
Unlike traditional treatments, Zuranolone directly targets the hormonal shifts post-childbirth, addressing a root cause often overlooked in conventional medicine.
Tag: Depression
Probiotics: A New Frontier in Depression Treatment
Considering root causes and potential contributing factors can lead to a more nuanced and comprehensive understanding of depression and anxiety.
The Top Ten Common Medications That Can Secretly Contribute To Depression.
These medications, commonly prescribed for nonpsychiatric conditions, have the potential to interact with antidepressants, masking or diluting their effectiveness. This highlights how interconnected our treatments can be.
L-Methylfolate: A Potential Boost to Antidepressant Efficacy
The evidence shows that patients receiving 15 mg/day of LMF for 30 days exhibited significantly greater reduction in Hamilton Depression Rating Scale (HDRS-17) scores and higher response rates compared to the placebo group. Additionally, a 12-month open extension trial indicated that 60% of initial non-responders eventually achieved remission with no serious adverse events.